Brief: Nasdaq Stockholm Submits Investigation With Request For AegirBio Delisting

Subgen AI AB

23/12/2022 08:02

Dec 23 (Reuters) - AegirBio AB  AEGIR.ST :
    * SAID ON THURSDAY, AEGIRBIO HAS TODAY BEEN INFORMED THAT
NASDAQ
STOCKHOLM HAS DECIDED TO SUBMIT ONGOING INVESTIGATION TO
DISCIPLINARY BOARD WITH A REQUEST FOR DELISTING
    * AEGIRBIO IS LISTED ON THE NASDAQ FIRST NORTH GROWTH MARKET
SINCE
2020
    * IF DECISION RESULTS IN DELISTING, CONVERTIBLE FINANCING OF
SEK
55 MLN OF CONVERTIBLE BONDS WITH ATTACHED WARRANTS AGREED WITH
ATLAS SPECIAL OPPORTUNITIES WILL NOT BE COMPLETED
    * CO HAS UNTIL JAN 2, 2023 TO INDICATE WHETHER IT WISHES TO
RESPOND IN WRITING OR REQUEST AN ORAL HEARING

Source text for Eikon:  urn:newsml:reuters.com:*:nWkr6X2v2p
Further company coverage:  AEGIR.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))